Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) reported Q2 EPS of $0.16, $0.22 better than the analyst estimate of ($0.06). Revenue for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE